BackNewAmsterdam Pharma Company NV Overview

NewAmsterdam Pharma Company NV Profit Margin

Profitability ratio analysis for NAMS.

Quarterly Profit Margin

-1593.45%
↓ 20.05% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-942.76%
↓ 237.44% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin